OBJECTIVES: The aim of this study was to determine whether behavioral mechanisms explain the association between depressive symptoms and myocardial infarction (MI) or death in individuals with coronary heart disease (CHD). BACKGROUND: Depressive symptoms are associated with increased morbidity and mortality in individuals with CHD, but it is unclear how much behavioral mechanisms contribute to this association. METHODS: The study included 4,676 participants with a history of CHD. Elevated depressive symptoms were defined as scores ≥4 on the Center for Epidemiologic Studies Depression 4-item Scale. The primary outcome was definite/probable MI or death from any cause. Incremental proportional hazards models were constructed by adding demographic data, comorbidities, and medications and then 4 behavioral mechanisms (alcohol use, smoking, physical inactivity, and medication non-adherence). RESULTS: At baseline, 638 (13.6%) participants had elevated depressive symptoms. Over a median 3.8 years of follow up, 125 of 638 (19.6%) participants with and 657 of 4,038 (16.3%) without elevated depressive symptoms had events. Higher risk of MI or death was observed for elevated depressive symptoms after adjusting for demographic data (hazard ratio [HR]: 1.41, 95% confidence interval [CI]: 1.15 to 1.72) but was no longer significant after adjusting for behavioral mechanisms (HR: 1.14, 95% CI: 0.93 to 1.40). The 4 behavioral mechanisms together significantly attenuated the risk for MI or death conveyed by elevated depressive symptoms (-36.9%, 95% CI: -18.9 to -119.1%), with smoking (-17.6%, 95% CI: -6.5% to -56.0%) and physical inactivity (-21.0%, 95% CI: -9.7% to -61.1%) having the biggest explanatory roles. CONCLUSIONS: Our findings suggest potential roles for behavioral interventions targeting smoking and physical inactivity in patients with CHD and comorbid depression.
OBJECTIVES: The aim of this study was to determine whether behavioral mechanisms explain the association between depressive symptoms and myocardial infarction (MI) or death in individuals with coronary heart disease (CHD). BACKGROUND:Depressive symptoms are associated with increased morbidity and mortality in individuals with CHD, but it is unclear how much behavioral mechanisms contribute to this association. METHODS: The study included 4,676 participants with a history of CHD. Elevated depressive symptoms were defined as scores ≥4 on the Center for Epidemiologic Studies Depression 4-item Scale. The primary outcome was definite/probable MI or death from any cause. Incremental proportional hazards models were constructed by adding demographic data, comorbidities, and medications and then 4 behavioral mechanisms (alcohol use, smoking, physical inactivity, and medication non-adherence). RESULTS: At baseline, 638 (13.6%) participants had elevated depressive symptoms. Over a median 3.8 years of follow up, 125 of 638 (19.6%) participants with and 657 of 4,038 (16.3%) without elevated depressive symptoms had events. Higher risk of MI or death was observed for elevated depressive symptoms after adjusting for demographic data (hazard ratio [HR]: 1.41, 95% confidence interval [CI]: 1.15 to 1.72) but was no longer significant after adjusting for behavioral mechanisms (HR: 1.14, 95% CI: 0.93 to 1.40). The 4 behavioral mechanisms together significantly attenuated the risk for MI or death conveyed by elevated depressive symptoms (-36.9%, 95% CI: -18.9 to -119.1%), with smoking (-17.6%, 95% CI: -6.5% to -56.0%) and physical inactivity (-21.0%, 95% CI: -9.7% to -61.1%) having the biggest explanatory roles. CONCLUSIONS: Our findings suggest potential roles for behavioral interventions targeting smoking and physical inactivity in patients with CHD and comorbid depression.
Authors: Russell V Luepker; Fred S Apple; Robert H Christenson; Richard S Crow; Stephen P Fortmann; David Goff; Robert J Goldberg; Mary M Hand; Allan S Jaffe; Desmond G Julian; Daniel Levy; Teri Manolio; Shanthi Mendis; George Mensah; Andrzej Pajak; Ronald J Prineas; K Srinath Reddy; Veronique L Roger; Wayne D Rosamond; Eyal Shahar; A Richey Sharrett; Paul Sorlie; Hugh Tunstall-Pedoe Journal: Circulation Date: 2003-11-10 Impact factor: 29.690
Authors: Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert Journal: Circulation Date: 2011-11-03 Impact factor: 29.690
Authors: Virginia J Howard; Robert F Woolson; Brent M Egan; Joyce S Nicholas; Robert J Adams; George Howard; Daniel T Lackland Journal: J Am Soc Hypertens Date: 2010 Jan-Feb
Authors: Nina Rieckmann; Matthew M Burg; Ian M Kronish; William F Chaplin; Joseph E Schwartz; Karina W Davidson Journal: Psychother Psychosom Date: 2011-06-30 Impact factor: 17.659
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Virginia J Howard; Dawn O Kleindorfer; Suzanne E Judd; Leslie A McClure; Monika M Safford; J David Rhodes; Mary Cushman; Claudia S Moy; Elsayed Z Soliman; Brett M Kissela; George Howard Journal: Ann Neurol Date: 2011-03-17 Impact factor: 10.422
Authors: Judith H Lichtman; J Thomas Bigger; James A Blumenthal; Nancy Frasure-Smith; Peter G Kaufmann; François Lespérance; Daniel B Mark; David S Sheps; C Barr Taylor; Erika Sivarajan Froelicher Journal: Circulation Date: 2008-09-29 Impact factor: 29.690
Authors: Karina W Davidson; Joseph E Schwartz; Susan A Kirkland; Elizabeth Mostofsky; Daniel Fink; Duane Guernsey; Daichi Shimbo Journal: Am J Cardiol Date: 2009-01-24 Impact factor: 2.778
Authors: William Whang; Laura D Kubzansky; Ichiro Kawachi; Kathryn M Rexrode; Candyce H Kroenke; Robert J Glynn; Hasan Garan; Christine M Albert Journal: J Am Coll Cardiol Date: 2009-03-17 Impact factor: 27.203
Authors: Suegene K Lee; Jay Khambhati; Tina Varghese; Eric P Stahl; Sonali Kumar; Pratik B Sandesara; Nanette K Wenger; Laurence S Sperling Journal: Clin Cardiol Date: 2017-08-28 Impact factor: 2.882
Authors: Carmela Alcántara; Paul Muntner; Donald Edmondson; Monika M Safford; Nicole Redmond; Lisandro D Colantonio; Karina W Davidson Journal: Circ Cardiovasc Qual Outcomes Date: 2015-03-10
Authors: Randy Cohen; Natalie C Gasca; Robyn L McClelland; Carmela Alcántara; David R Jacobs; Ana Diez Roux; Alan Rozanski; Steven Shea Journal: Am J Cardiol Date: 2016-03-02 Impact factor: 2.778
Authors: William M Schultz; Heval M Kelli; John C Lisko; Tina Varghese; Jia Shen; Pratik Sandesara; Arshed A Quyyumi; Herman A Taylor; Martha Gulati; John G Harold; Jennifer H Mieres; Keith C Ferdinand; George A Mensah; Laurence S Sperling Journal: Circulation Date: 2018-05-15 Impact factor: 29.690